Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Ryvlin

Showing results (11-20 of 316) with videos related to

Pageof 32
Sort By:
Current Opinion in Neurology|March 7, 2024
Editorial: Epilepsy advances in 2023Philippe Ryvlin
Current Opinion in Neurology|February 21, 2014
Patients' safety in the epilepsy monitoring unit: time for revising practicesSylvain Rheims, Philippe Ryvlin
The Lancet. Neurology|December 17, 2011
Epilepsy: new epidemiological and therapeutic perspectivesPhilippe Ryvlin, Sylvain Rheims
Expert Opinion on Pharmacotherapy|May 7, 2014
Pharmacotherapy for tonic-clonic seizuresSylvain Rheims, Philippe Ryvlin
Expert Review of Neurotherapeutics|May 4, 2012
Retigabine for partial onset seizuresSylvain Rheims, Philippe Ryvlin
Epilepsia|June 7, 2018
Standards for testing and clinical validation of seizure detection devicesSándor Beniczky, Philippe Ryvlin
Current Opinion in Neurology|February 25, 2026
Epilepsy advances in 2025Philippe Ryvlin, Daniel Friedman
Current Opinion in Neurology|February 24, 2026
SUDEP update 2026: recent advances in experimental and clinical researchPhilippe Ryvlin, Sylvain Rheims
Dialogues in Clinical Neuroscience|May 14, 2008
Epilepsy surgery: eligibility criteria and presurgical evaluationPhilippe Ryvlin, Sylvain Rheims
Neurologic Clinics|October 27, 2009
Sudden unexpected death in epilepsy (SUDEP): update and reflectionsLina Nashef, Philippe Ryvlin
Pageof 32

Showing results (11-20 of 316) with videos related to

Sort By:
Pageof 32
Current Opinion in Neurology|March 7, 2024
Editorial: Epilepsy advances in 2023Philippe Ryvlin
Current Opinion in Neurology|February 21, 2014
Patients' safety in the epilepsy monitoring unit: time for revising practicesSylvain Rheims, Philippe Ryvlin
The Lancet. Neurology|December 17, 2011
Epilepsy: new epidemiological and therapeutic perspectivesPhilippe Ryvlin, Sylvain Rheims
Expert Opinion on Pharmacotherapy|May 7, 2014
Pharmacotherapy for tonic-clonic seizuresSylvain Rheims, Philippe Ryvlin
Expert Review of Neurotherapeutics|May 4, 2012
Retigabine for partial onset seizuresSylvain Rheims, Philippe Ryvlin
Epilepsia|June 7, 2018
Standards for testing and clinical validation of seizure detection devicesSándor Beniczky, Philippe Ryvlin
Current Opinion in Neurology|February 25, 2026
Epilepsy advances in 2025Philippe Ryvlin, Daniel Friedman
Current Opinion in Neurology|February 24, 2026
SUDEP update 2026: recent advances in experimental and clinical researchPhilippe Ryvlin, Sylvain Rheims
Dialogues in Clinical Neuroscience|May 14, 2008
Epilepsy surgery: eligibility criteria and presurgical evaluationPhilippe Ryvlin, Sylvain Rheims
Neurologic Clinics|October 27, 2009
Sudden unexpected death in epilepsy (SUDEP): update and reflectionsLina Nashef, Philippe Ryvlin
Pageof 32